ASTHMA Flashcards
asthma abnormality
insufficient expiration
drugs used in asthma symptom relief
symptom relief: beta2 agonists (fast/long-acting), ipratropium, theophylline (less often)
drugs used in asthma long term control
corticosteroids; cromolyn, nedocromil; leukotriene modifiers; anti-IgE antibody
adjunct drugs used in asthma
antibiotics; mucolytics; oxygen (sedatives ci’d)
asthma last resort drugs
general anesthesia; muscle relaxation; controlled respiration; bronchial lavage; ketamine
summary of asthma drugs
http://o.quizlet.com/mZlov6PMUBNIRC-iseizdw.png
short-acting beta2 agonists
albuterol, levalbuterol, pirbuterol, terbutaline, metaprotenerol - for acute episodes
long-acting beta2 agonists
salmeterol, formoterol - for prophylaxis, long term therapy
beta2 agonists adverse effects
selectivity is relative; beta2 - muscle tremor, diabetogenic; beta1 - tachy, arrhythmogenic; loss of responsiveness; high dose continuous use - hypokalemia;
beta2 agonists uses
NOT anti-inflammatory; can be for preventative i.e. b4 going to gym
beta2 agonists and theophylline moa
can have over-additive effect!
theophylline characteristics
methylxanthine, related: caffeine, theobromine
theophylline pk
oral, sustained release; iv; many drug interactions; low therapeutic margin
theophylline adverse effects
cns - nervousness, tremor; cv - catecholamine release, +inotropy/chronotropy; arrhythmogenic; GI - hyperacidity, nausea
theophylline toxicities
convulsions, coma
theophylline uses
controversial -> dec in US (seizure risk - last choice); considered safe/useful in Europe esp in emergencies; more used for intermittent claudication
theophylline molecular moa
induce histone deacetylase -> dec inflammatory gene expression -> promotes corticoid action (unrelated to phosphodiesterase) -> controller/preventer drug
anticholinergics
ipratropium, thiotropium
ipratropium characteristics
polar compound; mostly local effect when used as inhalant; ineffective in 30% of asthma pt’s
ipratropium adverse effects
rare w/usual doses; dry mouth; NO tremor, tachy, dyskrinia (thickening mucous)
ipratropium uses
esp COPD w/vagal components; asthma in kids/old; psychogenic exacerbations of asthma; combo with beta2 agonists
thiotropium characteristics
much longer half-life; limited absorption from bronchial mucosa into system; some selectivity for M1, M3 receptors; labeled for COPD (combo tx)
corticosteroids inhalants
beclomethasone, budesonide, flunisolide, fluticasone
corticosteroids systemic
any e.g. prednisone, dexamethasone
corticosteroids adverse effects
depends on dose/asthma severity; inhalant low dose - local ae’s, insig systemic ae’s; inhalant high dose - local ae’s, minor systemic (avoid in kids); oral/systemic - severe systemic ae’s; single high dose (emergencies) - no systemic except risk of infection, aggravate DM
beclomethasone, budesonide, flunisolide, fluticasone pd
dec asthm symptoms; dec hyperreactivity; improve bronchial/pulmonary epithelial fxns
beclomethasone, budesonide, flunisolide, fluticasone pk
10% inhaled deployed into bronchial tree
beclomethasone, budesonide, flunisolide, fluticasone application
use application aids (e.g. spacer); in combo - apply 10 mins after b2 agonist inhaled
beclomethasone, budesonide, flunisolide, fluticasone local adverse effects
oral/esophageal candidiasis, hoarseness -> apply b4 meals
beclomethasone, budesonide, flunisolide, fluticasone systemic adverse effects
little bioavail -> minor ae’s compared to systemic corticosteroids
cromolyn, nedocromil characteristics
mast cell stabilizers
cromolyn, nedocromil pk
topical aerosol (for other indications - nasal spray, eye drops, oral)
cromolyn, nedocromil pd
inhibit early/late response by stabilizing mast cells, eosinophils -> dec hyperreactivity
cromolyn, nedocromil uses
preventative tx of antigen/exercise-induced asthma; INEFFECTIVE in acute exacerbation
cromolyn, nedocromil adverse effects
cough, airway irritation; RARE: drug allergies, gastroenteritis
leukotriene modifiers pd
effective in antigen/exercise-induced asthma, esp aspirin-asthma
leukotriene modifiers adverse effects
inc LFT, headache, dyspepsia
leukotriene modifiers
zileuton, montelukast, zafirlukast
zileuton moa
5-lipoxygenase antagonist; rarely used
montelukast, zafirlukast moa
LTD4 anatagonist, also blocks LTE4
leukotriene modifiers characteristics
less effective than inhaled corticosteroids, but used to dec cort. dose; definite position in asthma therapy not established
mucolytics pd
facilitate expectoration by dec viscosity of bronchial mucus
mucolytics
water (most important); acetylcysteine
acetylcysteine pd
disrupts S-S bonds in mucoproteins
mucolytics application
nebulizer, oral, iv, endotracheal lavage; tastes, smells like rotten eggs -> oral is best
mucolytics adverse effects
mechanical airway irritation, GI disturbances; allergic rxns; use w/CAUTION in severe acute asthma, gastric ulcer pt’s
asthma absolute contraindications
ALL beta-blockers; cholinergic drugs; centrally-acting anticholinergic drugs; codeine, dextrometorphane; aspirin, other nsaids
asthma relative contraindications
diuretics; ace-inhibitors; cns depressants; sedatives
treatment of mild intermittent asthma
reliever - inhaled short-acting beta2 agonist as needed - less than 1x/day; controller - none or cromolyn b4 allergen exposure
treatment of mild persistent asthma
reliever - inhaled short-acting beta2 agonist as needed, but less than 4x/day; controller - inhaled low dose corticosteroid or cromolyn, nedocromil
treatment of moderate persistent asthma
reliever - inhaled long-acting beta2 agonist; controller - inhaled corticosteroid
treatment of severe persistent asthma
reliever - (plus oral theophylline); controller - oral corticosteroid
asthma prevention of acute exacerbation
short oral prednisolone ‘rescue’ at anytime
emergency treatment of asthma
- oxygen, monitor
NO-NO’S in asthma emergency treatment
nedocromil, cromolyn; uncritical sedation